APVO Aptevo Therapeutics Inc

Aptevo Therapeutics Inc is a biosciences company. The Company is engaged in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics.

As of 06/30/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/20/2016
Outstanding shares:  5,007,242
Average volume:  140,624
Market cap:   $17,425,202
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -0.61
PB ratio:   14.23
PS ratio:   2.57
Return on equity:   491.13%
Net income %:   -426.29%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy